STOCK TITAN

Dianthus Therapeutics, Inc. (DNTH) Revenue by Year

DNTH

Dianthus Therapeutics, Inc. generated $2.0M in revenue in fiscal year 2025. This represents a decrease of 67.3% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Dianthus Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $2.0M
YoY -67.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DNTH Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Revenue$2.0M-67.3%$6.2M+120.6%$2.8M-56.0%$6.4M+334.8%$1.5MN/A$0$0$0$0

DNTH Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
RevenueN/AN/A$284K-78.6%$396K-81.8%$193K-89.6%$1.2M+33.1%$1.3M$2.2M+135.1%$1.9M$874KN/A$924K-21.2%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Dianthus Therapeutics, Inc. financials

Frequently Asked Questions

What was Dianthus Therapeutics, Inc.'s revenue in fiscal year 2025?

Dianthus Therapeutics, Inc. generated $2.0M in revenue in fiscal year 2025.

How fast is Dianthus Therapeutics, Inc.'s revenue growing?

Dianthus Therapeutics, Inc. (DNTH) revenue fell by 67.3% year over year, from $6.2M to $2.0M in fiscal year 2025.

How has Dianthus Therapeutics, Inc.'s revenue changed over the years?

Across the 10 fiscal years this page covers, Dianthus Therapeutics, Inc. (DNTH) revenue went from $0 in fiscal year 2016 to $2.0M in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Dianthus Therapeutics, Inc. (DNTH) reported on that line in every period on record.